Pasithea Therapeutics Corp.
Recent Filings
All 303 filings →| Form | Description | Date |
|---|---|---|
| SCHEDULE 13G | — | Feb 27, 2026 |
| 8-K | CURRENT REPORT | Feb 20, 2026 |
| SCHEDULE 13G/A | — | Feb 17, 2026 |
| SCHEDULE 13G/A | — | Feb 17, 2026 |
| SCHEDULE 13G | — | Feb 12, 2026 |
| S-8 | REGISTRATION STATEMENT | Jan 30, 2026 |
| 8-K | CURRENT REPORT | Jan 28, 2026 |
| EFFECT | — | Jan 27, 2026 |
| POS AM | POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3 | Jan 26, 2026 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | Dec 29, 2025 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Date |
|---|---|---|---|---|
| STEINMAN LAWRENCE | — | Purchase | 133,333 @ $0.75 | Nov 28, 2025 |
| Schneiderman Daniel H | Chief Financial Officer | Award / Grant | 26,667 @ $0.75 | Nov 28, 2025 |
| Marques Tiago | Chief Executive Officer | Purchase | 33,333 @ $0.75 | Nov 28, 2025 |
| Dumesnil Simon | — | Purchase | 33,333 @ $0.75 | Nov 28, 2025 |
| Leahy Emer | — | Award / Grant | 33,333 @ $0.75 | Nov 28, 2025 |
| Marques Tiago | Chief Executive Officer | Sale | 960 @ $0.83 | May 12, 2025 |
| Novak Alfred J | — | Award / Grant | 750 @ $5.61 | Jun 13, 2024 |
| STEINMAN LAWRENCE | — | Purchase | 30,000 @ $0.43 | Jun 2, 2023 |
| STEINMAN LAWRENCE | — | Award / Grant | 5,000 @ $0.98 | Nov 28, 2022 |
| Marques Tiago | Chief Executive Officer | Award / Grant | 5,000 @ $1.00 | Nov 25, 2022 |